Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GenVec has completed its previously announced registered direct offering of 11.26 million shares of its common stock and warrants to purchase 2.25 million shares of its common stock.
Subscribe to our email newsletter
The shares of common stock and warrants were offered in units consisting of one share of common stock and a warrant to purchase 0.20 shares of common stock at a per unit price of $1.51. The warrants have a term of five years and an exercise price of $2.016 per share.
The aggregate gross proceeds of the offering were approximately $17 million and aggregate net proceeds, after deducting the placement agents’ fee and estimated offering expenses payable by GenVec, are expected to be approximately $15.8 million.
Merriman Curhan Ford acted as lead placement agent, and Boenning & Scattergood acted as co-placement agent in connection with this transaction.